Search

26 Oct 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. ISOLDE: Building High Quality Macromolecular Models into Low Resolution Experimental Maps. ISOLDE is a ChimeraX plugin (installable via its built-in Tool Shed) designed to ease the task

10 Aug 2023: Co-founded by Dr Tongtong Zhu (CEO), Dr Yingjun Liu (CTO) and Professor Rachel Oliver (CSO), Porotech had hit upon and developed a new class of porous gallium nitride (GaN) semiconductor ... This latest funding will accelerate our work to ensure that

26 Oct 2023: MiniCPC led by Molly Haugen (Department of Engineering). New Battery Co. led by Ismail Sami (Department of Materials Science and Metallurgy).

22 Feb 2023: We are pleased to announce that Cambridge Enterprise, the University of Cambridge Enterprise Fund IV, managed by Parkwalk, and Cambridge Innovation Capital...

1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – University of Cambridge staff and students. How we use your personal information – University of Cambridge staff and students. This policy

1 Aug 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. How we use your personal information – subscribers to digital newsletters and updates. How we use your personal information – subscribers to digital newsletters and updates. This

22 Feb 2023: 19 September 2019. New agreement with Cambridge spin-out PredictImmune lets SLE join pipeline. ... The expanded agreement will allow PredictImmune to evolve its product development pipeline, accelerating its commercial offering into this new therapeutic

22 Feb 2023: The continued support from our seed investors and interest from new investors demonstrates the robustness of our technology and underlines the rapid progress Aqdot is making. ... Tim Wright, CEO at Aqdot, said “the continued support from our seed

22 Feb 2023: The latest technologies stemming from research at Oxford and Cambridge were presented to investors at an event held at the Royal Society of Chemistry.

22 Feb 2023: Stem cells are revolutionising medicine by enabling new approaches for disease modelling, precision medicine and development of new therapeutics. ... The need for quality and reproducibility in stem cell biology and exciting new areas such as organoids

23 Feb 2023: One third of this year’s consultancy projects were from new academic consultants. ... Cambridge Enterprise also invests intellectual property and cash to create new companies and ventures based on Cambridge research.

23 Feb 2023: Share:. The Discovery Fund recently made its second investment in a new University spin-out that is developing water droplets that serve as ‘miniature test tubes’. ... Dr Geraldine Rodgers. Dr Frank Craig has been recruited as CEO, and the

5 Jul 2023: Apollo is now advancing into clinical development as well as identifying new programmes. ... profi le. Evidence included scientifi c papers, government reports, and local news articles.

22 Feb 2023: sectors, where they will be used to model a range of diseases and accelerate the development of new treatments. ... This funding is helping develop new therapies and treatments for conditions which affect millions worldwide, including liver disease,

22 Feb 2023: technology. Proteins and their behaviour are crucial to understanding how diseases develop, identifying the way that drugs interact with their targets, and developing new methods for matching the right treatment to ... Joining the round as new investors

22 Feb 2023: Trials of the kits conducted at leading research centres around the world have already begun to yield new insights into genome function and highlighted the advantages of TrueMethyl relative to traditional ... Consequently, this pioneering analytical

3 Jul 2023: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on.

22 Feb 2023: The new funding will help drive DefiniGEN to profitability and enable the Company to achieve the following:. ... We are delighted to have raised the funds that will allow us to deliver new market-leading products to our customers and assist them in

22 Feb 2023: The Postdoc Business Plan Competition was won by Accelerated Materials which helps businesses create innovative products with nanomaterials

22 Feb 2023: We are delighted to announce that Cambridge Enterprise and the Parkwalk Opportunities Fund and have completed an investment in PredictImmune Limited, a...

22 Feb 2023: Nyobolt—a cutting-edge battery company that is defining a new category of ultra-high power technology—has secured $10 million in Series A funding. ... The funding will enable Nyobolt to expand globally, building new facilities and growing its

23 Feb 2023: Drug discovery company Storm Therapeutics announces the appointment of Keith Blundy as CEO and Tim Edwards as Chairman.

22 Feb 2023: 12 December 2013. Definigen raises £1.3m in funding. Share:. Cambridge spin-out Definigen has completed a new funding round worth £1.3 million, led by Cambridge Enterprise. ... Definigen will use the funding to accelerate production and introduce new

22 Feb 2023: Jonathan Milner and other local angels have formed a syndicate with the Enterprise Fund to support this exciting new venture. ... The scheme allows individuals to invest in new companies while benefitting from generous tax incentives.

23 Feb 2023: Sphere Fluidics’ technology enables the study of the mechanism of cancer cell resistance to chemotherapy, the generation of new enzymes and identification of novel microbial strains.

23 Feb 2023: months are just some of the technologies being developed by new companies based on Cambridge research, with funding support from the University seed funds. ... The companies receiving either new or follow-on support included Aqdot, CamSemi, DefiniGEN,

22 Feb 2023: He added: “We would also like to welcome our new CEO, Dr Fedja Bobanovic, who has an exceptional track record of generating growth in life sciences businesses.“. ... Somu Subramanian, new board member and founding partner of New Science Ventures,

22 Feb 2023: 17 March 2020. DIOSynVax works towards vaccine against COVID-19. Share:. It is hard now to conceive that two months ago few people had heard of the new coronavirus. ... In the past few years, Heeney has won significant funding and investment from the

23 Nov 2023: to share best practice and open up new avenues of agri-tech research.

22 Feb 2023: Current investors New Science Ventures and Syncona Partners. In conjunction with the fundraising, Tom Hulme, GV general partner, will join CEGX’s board of directors and co-founder Dr Bobby ... New CEO Dr Geoff Smith joins CEGX from Illumina, where he

23 Feb 2023: This year we were pleased to sponsor two new prizes: the Cambridge Enterprise Academic Entrepreneur of the Year Award and the Cambridge Enterprise Lifetime Achievement Award. ... In addition to the two new awards sponsored by Cambridge Enterprise, we

23 Feb 2023: Share:. Evotec AG today announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas. ... STORM is the only company harnessing the power of RNA

23 Feb 2023: The second prize of £10,000 went to NeutroCheck, which is developing a new medical device that will deliver more efficient healthcare for cancer patients worldwide. ... an entirely new class of bio-material; and Textile Two Dimensional, which is

22 Feb 2023: During this period, 400 new knowledge and technology transfer transactions were completed, bringing the portfolio to over 700 active equity, consultancy and licence agreements under management.

15 Nov 2023: The company’s OpTiMus platform can sidestep this issue by creating a near unlimited database of optimal TCRs, which can act as building blocks for new therapies. ... We are proud to be alongside Allan and the team as they pioneer a new era in cancer

21 Mar 2023: It is the result of a culture of excellence, underpinned by a depth and breadth of teaching, research and innovation that connects the discovery of new knowledge with the expertise to

22 Feb 2023: months. “We help businesses gain a comprehensive understanding of risk, particularly in new and emerging markets, by leveraging the observation power of the internet”, says Hartley. ... The company has also added a new non-executive chairman to the

22 Feb 2023: 8power Limited, Cambridge start up developing smart sensors for industrial applications, has won the 7th CW Discovering Startups Competition.

22 Feb 2023: The new investment will enable Nu Quantum to develop its technology into full prototypes over the next 18 months.

22 Feb 2023: We now welcome a fantastic group of investors who share our vision and passion and we are excited to enter a new phase of growth of the company.

22 Feb 2023: Prof Sir Colin Humphreys, Chairman and Co-Founder of Paragraf, said: “Graphene has been called the new wonder material, because of its potential to transform a range of industries such as

22 Feb 2023: Dr Giorgia Longobardi, founder and CEO of Cambridge GaN Devices Ltd (CGD), has been named as a winner of the RAEng Engineers...

13 Oct 2023: Share:. An ambitious new strategy to nurture and grow the innovation ecosystem in Cambridge was unveiled on Wednesday. ... This new home-grown innovation strategy, which has had input from 200 organisations, including Cambridge Enterprise, the University

22 Feb 2023: Share:. Carrick Therapeutics Ltd, a unique new venture in cancer treatment, launched today, having secured $95M in funding. ... These investors have impeccable track records of accelerating the development of cutting edge science into new therapies.

23 Feb 2023: It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary. ... Dr Rob Marchmont. Dr Rob Marchmont, Fluidic’s Commerical Director, attended the awards ceremony and

22 Feb 2023: Share:. Cambridge Enterprise portfolio company CellCentric has out-licensed the development and commercialisation of a new programme which may lead to new cancer therapeutics. ... This new agreement demonstrates our commitment to researching and

23 Feb 2023: Share:. The award, from Global University Venturing, was in recognition of the work which Cambridge Enterprise does in support of new companies based on University research.

22 Feb 2023: The objective is to build a portfolio of new products to complement and enrich PredictImmune’s prognostic test pipeline in the coming years. ... An expectation of further growth and global commercial development also attracted two new major investors,

7 Aug 2023: MiniCPC led by Molly Haugen (Department of Engineering). New Battery Co.

22 Feb 2023: Innovations in stem cell biology over the last decade have given rise to applications in disease modelling, drug screening, precision medicine and development of new therapeutics. ... research and regenerative medicine and to facilitate the development